Showing results (41-50 of 447) with videos related to
Sort By:
Pageof 45
Cancers|August 26, 2023
Whole Exome Sequencing of Thymoma Patients Exhibiting Exceptional Responses to Pemetrexed MonotherapyTomohiro Tanaka, Yasushi Goto, Masafumi Horie, et al.Thoracic Cancer|February 21, 2024
Adenovirus pneumonia mimicking osimertinib-induced pneumonitis in a patient with advanced NSCLC with EGFR mutation: A case reportToru Imai, Tatsuya Yoshida, Yuichiro OheJapanese Journal of Clinical Oncology|October 12, 2023
Biomarkers of immunotherapy for non-small cell lung cancerMasayuki Shirasawa, Tatsuya Yoshida, Yuichiro OheMedical Oncology (Northwood, London, England)|March 18, 2020
Clinical characteristics of adrenal insufficiency as an immune-related adverse event in non-small-cell lung cancerHanae Ida, Yasushi Goto, Jun Sato, et al.Lung Cancer (Amsterdam, Netherlands)|March 13, 2023
Impact of ramucirumab pharmacokinetics in combination with docetaxel on the efficacy and survival in patients with advanced non-small cell lung cancerKazumasa Akagi, Shigehiro Yagishita, Mayu Ohuchi, et al.Japanese Journal of Clinical Oncology|April 21, 2021
Feasibility of next-generation sequencing (Oncomine™ DX Target Test) for the screening of oncogenic mutations in advanced non-small-cell lung cancer patientsYuki Takeyasu, Tatsuya Yoshida, Noriko Motoi, et al.Clinical Lung Cancer|June 1, 2022
Concurrent High PD-L1 Expression and CD8+ Immune Cell Infiltration Predict PD-1 Blockade Efficacy in Advanced EGFR-Mutant NSCLC PatientsYukiko Shimoda, Ryota Shibaki, Tatsuya Yoshida, et al.Lung Cancer (Amsterdam, Netherlands)|September 18, 2022
Early change in the clearance of pembrolizumab reflects the survival and therapeutic response: A population pharmacokinetic analysis in real-world non-small cell lung cancer patientsMayu Ohuchi, Shigehiro Yagishita, Hitomi Jo, et al.British Journal of Cancer|November 30, 2020
Prognostic impact of peripheral blood neutrophil to lymphocyte ratio in advanced-stage pulmonary large cell neuroendocrine carcinoma and its association with the immune-related tumour microenvironmentMasayuki Shirasawa, Tatsuya Yoshida, Hidehito Horinouchi, et al.Translational Lung Cancer Research|July 10, 2023
Concordance between cryobiopsy and forceps biopsy specimens in assessment of immunohistochemistry staining for non-small cell lung carcinomaKanako Nishimatsu, Yuji Matsumoto, Jumpei Kashima, et al.Pageof 45